We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medicare could save billions of dollars each year if the federal government negotiated directly with drug companies for all federal drug benefit programs including Medicare Part D, according to a new report released Wednesday by Sen. Claire McCaskill (D-Mo.). Read More
Demopoulos spent a large part of his life researching glutathione and he is credited by Molecular Defenses Corporation as inventing the free radical pathology field. Read More
Biosimilar products have been licensed in some countries as generics or as small molecule drugs with supporting data that don’t meet the WHO’s regulations. Read More
The World Health Organization (WHO) invited comments on a draft question-and-answer document that aims to clarify its 2009 guidelines on the evaluation of biosimilars. Read More
The company said it continues to believe the drug-device combination “could bring value to the management of pain and will assess the next steps in the context of the company’s overall mission.” Read More